UK rollout of AZ/Oxford Covid-19 vaccine: what you need to know
The UK has approved its second Covid-19 vaccine for emergency use: AZ/Oxford’s candidate. This is welcome news given how ...
GlobalData on MSN4d
Pfizer and AstraZeneca debate: when “the greater good” matters
When “the Greater Good” Matters The business pages, and now the mainstream media, have been dominated over the last week with news of Pfizer’s proposed $106bn takeover of AstraZeneca, which would make ...
AstraZeneca (LSE:AZN) Gains FDA Approval for Fasenra in EGPA, Boosting Revenue Growth and Market Position
AstraZeneca (LSE:AZN) is navigating a period of robust growth and strategic challenges. Recent developments include an 18% ...
AstraZeneca: Poised for Growth with Promising Innovation Pipeline and Attractive Valuation
In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Buy rating on AstraZeneca (AZN – Research Report), with a ...
Could The Market Be Wrong About AstraZeneca PLC (LON:AZN) Given Its Attractive Financial Prospects?
AstraZeneca (LON:AZN) has had a rough month with its share price down 9.1%. But if you pay close attention, you ...
Down another 6% in a week! So will the GSK share price ever recover?
The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...
AstraZeneca: A Buy Rating Based on Promising Pipeline and Regulatory Prospects
AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain ...
AstraZeneca PLC: FluMist approved for self-administration in US
FluMist approved for self-administration in the US Only influenza vaccine approved for self- or caregiver-administration at home, expanding options for influenza protection FluMist ...
Healthy 27-year-old died after NHS wrongly gave him AstraZeneca Covid jab
A healthy 27-year-old died from a reaction to the AstraZeneca vaccine after NHS mistakes meant he wrongly got the jab, a ...
Medscape2d
Best Survival Outcomes With Neoadjuvant Immunotherapy in Melanoma
Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...
prmoment.com4d
Good and Bad PR: AstraZeneca’s good robot, Murdoch goes wrong with Rightmove and Asos keeps schtum on returns
The first Christmas campaigns started in earnest last week, so it must be September. Murdoch makes money moves Rightmove ...
The greatest British shares to invest in: Their steady and dependable growth is a testament to the power of UK plc
Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...